Showing 7081-7090 of 9517 results for "".
Know Your Lesions: The Many Variations of Seborrheic Keratosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/know-your-lesions-the-many-variations-of-seborrheic-keratosis/20679/SKs are benign lesions that may be removed for medical or aesthetic reasons. It's essential to distinguish SKs from malignant lesions.Update on the Safety and Efficacy of Nicotinamide for Skin Cancer Chemoprevention
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-the-safety-and-efficacy-of-nicotinamide-for-skin-cancer-chemoprevention/57251/Nicotinamide, also known as niacinamide, is a water-soluble vitamin B3 derivative that has long been associated with beneficial impacts on skin cancer risk.Fine Particulate Matter and Eczema
https://practicaldermatology.com/issues/july-2025/fine-particulate-matter-and-eczema/36512/The primary objective of this study was to investigate the potential associations between fine particulate matter (specifically PM2.5) exposure and eczema. Researchers on this study set out to explore whether the odds of having eczema would increase with greater PM2.5 exposure, and to identify whethMeet the New Crop of Pigment Correctors
https://practicaldermatology.com/topics/pigmentary-disorders/meet-the-new-crop-of-pigment-correctors/23767/Hydroquinone is no longer the only game in town. In fact, alternatives are now more readily available and show good efficacy.Understanding the MOA of NEMLUVIO®: Targeting IL-31 Signaling in Neuroimmune Skin Diseases
https://practicaldermatology.com/videos/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/Watch Dr Peter Lio as he explains the role of IL-31, a key neuroimmune cytokine, in AD and PN and provides an in depth overview of the mechanism of action for NEMLUVIO®.On Dosage and Diet: Isotretinoin 101
https://practicaldermatology.com/topics/general-topics/on-dosage-and-diet-isotretinoin-101/21445/Isotretinoin is one of the most essential agents in the treatment of acne, but dietary and dosage considerations must be made to maximize efficacy. Author:Joshua Zeichner, MDThe Do’s and Don’ts of Managing Pediatric Hidradenitis Suppurativa
https://practicaldermatology.com/topics/rare-disease/the-dos-and-donts-of-managing-pediatric-hidradenitis-suppurativa/54450/Pediatric HS is often underrecognized, especially in prepubertal children, leading to delayed treatment and preventable disease progression. Clinicians should adapt diagnostic criteria and proactively screen high-risk groups, such as patients with severe acne. Children with HS frequently have assocOptimizing Isotretinoin Treatment: Keys to Successful Prescribing and Management
https://practicaldermatology.com/topics/practice-management/optimizing-isotretinoin-treatment-keys-to-successful-prescribing-and-management/21193/Embraced by the dermatology community, isotretinoin is still considered controversial by some patients. Here are tips on navigating the prescribing process to improve patient comfort and adherence.10 Tips for Managing Hidradenitis Suppurativa
https://practicaldermatology.com/issues/april-2025/10-tips-for-managing-hidradenitis-suppurativa/35602/In an effort to assist the working dermatologist, we have provided the following HS management guide, which supplies actionable insights into optimizing HS management, emphasizing the importance of individualized care, timely interventions, and collaboration with multidisciplinary teams.The State of Private Equity in 2024: Impact on the Practice of Dermatology
https://practicaldermatology.com/columns/practice-management/state-private-equity-2024-impact-practice-dermatology/27173/Physician Growth Partners recently published a white paper, “State of Dermatology Private Equity,” that evaluated market trends, strategies, and more. Practical Dermatology® spoke exclusively with CEO Michael Kroin about how the evolution of private equity is impacting the everyday practitioner and